What will gray vendors do to compete with new highly reduced prices for US GLP drugs?

[AndyPanda]

Can they survive with $150 a month name brand drugs? I get that it’s still a little cheaper to go with gray, but they will need to compete.

 

[mraajr]

When you can buy ten 30 mg vials for around that price, I think the grey vendors will be just fine. There are a few single vial vendors in the U.S where you can get five vials for that price. For most people $150 a month extra is a lot.

The only thing Big Pharma has on the grey market is that there is a relatively large percentage of the population that does not have the same willingness to accept risk that a lot of us do. That will cause them to pay the $150 rather than buy grey. The other reason most people do not buy grey is because they simply do not know that market exists.

 

[Foggy-Hollow]

It will be 150 for the oral meds.

Shots will be 350.

 

[FNG33]

Tirzepatide price in the article is still 3000% more then gray a month based upon a 10mg dose. Chinese vendors will be fine. Compounding may take a hit.

 

[byefatlicia]

Grey market prices will continue to fall at the same rate they are now. This certainly won't hurt them. The more the word is spread about grey, the more volume they'll get.